Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 294)
Posted On: 11/05/2018 12:03:31 PM
Post# of 36566
Posted By: docj
From Goldman:

Going forward, we will re-visit GNBT as additional details regarding Veneto, future acquisitions and product development, emerge. We maintain that even at a major price/sales discount, the pre-dividend price target (and prior to any adjustments), these shares could hit the $40 mark, which would represent just over $54M, or .5x Vento sales. Thus, investors would pay little for that business and get the other business lines for free. As the Street begins to take notice and is aware of the biz dev efforts and results, GNBT could be a huge winner beginning early next year.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site